Competition in health care research
Learn about the current state of competition in health insurance markets across the U.S. and review in-depth analysis on market concentration.
AMA advocacy efforts
The AMA advocates at the federal and state levels on key health care issues impacting patients and physicians. See updates of some of the recent efforts.
Nov. 11, 2022: National Advocacy Update
Bipartisan House letter coincides with launch of APM coalition and more in the latest National Advocacy Update.
Nearly 80% of Medicare Advantage markets are “highly concentrated”
AMA analysis of markets in 380 metropolitan statistical areas finds that nearly 80% are “highly concentrated,” according to federal guidelines.
New study shows Medicare Advantage markets lack competition
Annual AMA analysis monitoring competition in health insurance markets now includes insight on Medicare Advantage
Oct. 8, 2021: Advocacy Update spotlight on health insurance competition study
2021 update to "Competition in Health Insurance: A Comprehensive Study of U.S. Markets," in this week's Advocacy Update spotlight.
Competition continues to shrink in U.S. health insurance markets
Health insurance concentration has risen in 57% of U.S. markets, and 73% of all markets are considered “highly concentrated” by federal regulator standards.
How latest surprise-billing rule entrenches health insurers’ power
Over 70% of nation’s health insurance markets are highly concentrated. New Biden administration rule represents a gift to the insurance industry.